Kaisa Health Group Holdings (HKSE:00876) Moat Score: 0/10 (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00876 Kaisa Health Group Holdings Ltd HKSE:00876
40 GF Score
Price HK$2.86
GF Value HK$0.95
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Kaisa Health Group Holdings Moat Score?

Kaisa Health Group Holdings has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Kaisa Health Group Holdings has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Kaisa Health Group Holdings might have No Moat - No discernible moat.

Kaisa Health Group Holdings  (HKSE:00876) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Kaisa Health Group Holdings Moat Score Related Terms

HKSE:00876
40GF Score
Kaisa Health Group Holdings Ltd HKSE:00876
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kaisa Health Group Holdings (HKSE:00876) Overvalued in 2026?

Based on GuruFocus' analysis, Kaisa Health Group Holdings stock appears to be overvalued. The current stock price of HK$2.86 is trading 200.5% above its estimated GF Value™ of HK$0.95. GuruFocus considers Kaisa Health Group Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:00876:

  • Moat Score: 0
  • GF Value™: HK$0.95 vs. price of HK$2.86 (200.5% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00876 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kaisa Health Group Holdings Business Description

Address 99 Queen\'s Road Central, 30th Floor, The Center, Central, Hong Kong, HKG
Kaisa Health Group Holdings Ltd, through its subsidiaries are mainly engaged in the manufacturing and sale of dental prosthetics and implant instruments, and the provision of sports rehabilitation services. The Group operates in two reportable segments: Dental Business, which consists of manufacturing and trading in dental products; and the Health Care Business, which provides services for sport rehabilitation, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, other rehabilitation services, and health leisure business. The majority of its revenue is generated from the Dental business segment. Geographically, the Group generates maximum revenue from the People's Republic of China, and the rest from other countries.
40GF Score

Get the complete analysis for HKSE:00876

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.86
Price
HK$0.95
GF Value